Medtronic Bets On Future Mazor Robotics Spine Surgery Systems
Medtronic is putting its sales and marketing power behind Israel-based Mazor Robotics with new commercial agreement and investment deals, both announced May 18.
You may also be interested in...
Zimmer Biomet will gain through a $130m deal a spine-surgery robot that may be able to compete in the emerging minimally invasive spine surgery segment. The technology will also complement Zimmer Biomet’s other recent acquisition in spine surgery devices.
SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.
No device-related warning letters were released by the US FDA the week of 19 January.